Discover
STOK
Stoke Therapeutics, Inc.
32.71
2 x 24.02
2 x 41.19
bid
ask
-
0.01
0.03%
2 @ 04:00 PM
31.76 -0.95 (2.90%)
| Ytd | 3.06% | |
| 1y | 180.77% |
32.09
day range
33.50
11.31
52 week range
40.22
| Open | 32.63 | Prev Close | 32.72 | Low | 32.09 | High | 33.50 | Mkt Cap | 2.04B |
| Vol | 1.17M | Avg Vol | 692.18K | EPS | -2.86 | P/E | N/A | Forward P/E | -10.54 |
| Beta | 1.19 | Short Ratio | 20.80 | Inst. Own | 119.77% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 31.43 | 200-d Avg | 31.13 | 1yr Est | 45.10 |
| Income Statement | |||
| Total Revenue | 6.23M | ||
| Revenues (USD) | 6.23M | ||
| Gross Profit | 6.23M | ||
| Operating Expenses | 59.65M | ||
| Research and Development Expense | 39.67M | ||
| Selling, General and Administrative Expense | 19.97M | ||
| Operating Income | -53.42M | ||
| Interest Expense | -3.40M | ||
| Net Income | -50.00M | ||
| Net Income Common Stock | -50.00M | ||
| Net Income Common Stock (USD) | -50.00M | ||
| Consolidated Income | -50.00M | ||
| Earnings per Basic Share | -0.79 | ||
| Earnings per Basic Share (USD) | -0.79 | ||
| Earnings per Diluted Share | -0.79 | ||
| Earning Before Interest & Taxes (EBIT) | -53.40M | ||
| Earning Before Interest & Taxes (USD) | -53.40M | ||
| Weighted Average Shares | 63.06M | ||
| Weighted Average Shares Diluted | 63.06M | ||
| Balance Sheet | |||
| Cash and Equivalents | 155.66M | ||
| Cash and Equivalents (USD) | 155.66M | ||
| Investments | 258.59M | ||
| Investments Current | 187.89M | ||
| Investments Non-Current | 70.71M | ||
| Trade and Non-Trade Receivables | 4.45M | ||
| Current Assets | 366.68M | ||
| Property, Plant & Equipment Net | 5.89M | ||
| Total Assets | 443.28M | ||
| Current Liabilities | 40.81M | ||
| Total Liabilities | 48.40M | ||
| Accumulated Retained Earnings (Deficit) | -547.72M | ||
| Accumulated Other Comprehensive Income | -115.00K | ||
| Shareholders Equity | 394.88M | ||
| Shareholders Equity (USD) | 394.88M | ||
| Assets Non-Current | 76.60M | ||
| Deferred Revenue | 16.67M | ||
| Liabilities Non-Current | 7.59M | ||
| Trade and Non-Trade Payables | 6.84M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.05M | ||
| Net Cash Flow from Financing | 84.33M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 74.44M | ||
| Capital Expenditure | -353.00K | ||
| Issuance (Purchase) of Equity Shares | 84.33M | ||
| Net Cash Flow from Investing | 50.69M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 51.05M | ||
| Net Cash Flow from Operations | -60.58M | ||
| Share Based Compensation | 8.75M | ||